An2 Therapeutics, Inc. · NASDAQ:ANTX

Aziz Kabeer received 2,852 An2 Therapeutics, Inc. shares as an award (Form 4)

Traded Jul 10, 2026 · Filed Jul 10, 2026

On Jul 10, 2026, Aziz Kabeer (Director) received 2,852 An2 Therapeutics, Inc. shares as an award, leaving 59,106 shares. Filed Jul 10, 2026 (Form 4).

Awarded
2,852 shares
Holding after
59,106 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 10, 2026Common StockAward2,85259,106Direct

Source

View original at SEC

Related